# Doxercalciferol (gz427397) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/doxercalciferol-gz427397

> Doxercalciferol (gz427397), sponsored by Sanofi (SNY): 1 recorded catalyst.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | doxercalciferol (gz427397) |
| Codes | GZ427397 |
| Sponsor | Sanofi (SNY) https://sec-api.dev/companies/sny/catalysts |
| Indications | [Secondary Hyperparathyroidism-Chronic Kidney Disease](https://sec-api.dev/indications/secondary-hyperparathyroidism-chronic-kidney-disease) |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### June 11, 2025: primary completion

- Status: withdrawn. Date confidence: exact. Stage: 3. Indication: Secondary Hyperparathyroidism-Chronic Kidney Disease.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- ClinicalTrials.gov: "NCT02859896 (Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis): Overall Status TERMINATED; Phase PHASE3; Primary Completion 2025-06-11 (ACTUAL); Lead Sponsor Sanofi; Results First Posted 2026-07-02." https://clinicaltrials.gov/study/NCT02859896

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/doxercalciferol-gz427397.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Doxercalciferol (gz427397) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/doxercalciferol-gz427397

```bibtex
@misc{secapidev_pdufa_doxercalciferol_gz427397_20261116,
  title        = {Doxercalciferol (gz427397) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/doxercalciferol-gz427397}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_doxercalciferol_gz427397_20261116","title":"Doxercalciferol (gz427397) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/doxercalciferol-gz427397","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
